Linezolid
6,913 views
Antibiotics / Antiparasitics
- Penicillin Overview
- Penicillinase-Sensitive vs. Penicillinase-Resistant Penicillins
- Anti-Pseudomonal Penicillins
- Cephalosporins Overview
- 1st Generation Cephalosporins
- 2nd Generation Cephalosporins
- 3rd Generation Cephalosporins
- 4th Generation Cephalosporins
- 5th Generation Cephalosporins
- Carbapenems
- Monobactams (Aztreonam)
- Vancomycin
- Aminoglycosides
- Tetracyclines
- Tigecycline
- Chloramphenicol
- Clindamycin
- Linezolid
- Macrolides
- Polymyxins
- Sulfonamides
- Dapsone
- Trimethoprim
- Fluoroquinolones
- Daptomycin
- Metronidazole
- Rifamycins (Rifampin, Rifabutin)
- Isoniazid
- Pyrazinamide
- Ethambutol
- Chloroquine
Summary
Linezolid is a last-resort antibiotic used to treat bacterial infections resistant to other antibiotics. Linezolid works by binding to the 50S ribosomal subunit of bacteria to prevent bacterial protein synthesis. Adverse effects include bone marrow suppression, neuropathy, and serotonin syndrome.
Key Points
- Linezolid
- Mechanism
- Binds to 50S subunit of bacterial ribosomes
- Prevents formation of initiation complex and inhibits bacterial protein synthesis
- Binds to 50S subunit of bacterial ribosomes
- Clinical Use
- Gram-positive species including MRSA and VRE
- Usually used as a last-resort for multi-drug resistant infections
- Adverse Effects
- Bone marrow suppression
- Anemia, leukopenia, and thrombocytopenia are common
- Neuropathy
- Includes optic neuritis and peripheral neuropathy
- Serotonin syndrome
- Due to partial monoamine oxidase (MAO) inhibition
- Risk is compounded with use of other serotonergic drugs (e.g. MAOIs, SSRIs)
- Bone marrow suppression
- Resistance
- Point mutation of ribosomal RNA changes 50S binding site
- Mechanism